Background: To date, no clinical trial has compared the efficacy and toxicity of the three EMA registered INSTI in a face-to-face study of first line regimens.
Durability of integrase inhibitors (INSTI) regimens in the clinical setting: data from the ICONA Foundation Cohort.
G. Nunnari;G. F. Pellicanò.
2018-01-01
Abstract
Background: To date, no clinical trial has compared the efficacy and toxicity of the three EMA registered INSTI in a face-to-face study of first line regimens.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
